Compare ATRC & TSLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATRC | TSLX |
|---|---|---|
| Founded | 2000 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2005 | 2014 |
| Metric | ATRC | TSLX |
|---|---|---|
| Price | $37.83 | $20.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 10 |
| Target Price | ★ $52.22 | $23.50 |
| AVG Volume (30 Days) | 538.1K | ★ 589.8K |
| Earning Date | 02-17-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 10.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.04 |
| Revenue | ★ $518,304,999.00 | $464,512,000.00 |
| Revenue This Year | $16.94 | N/A |
| Revenue Next Year | $12.54 | N/A |
| P/E Ratio | ★ N/A | $9.77 |
| Revenue Growth | ★ 15.80 | N/A |
| 52 Week Low | $28.29 | $18.58 |
| 52 Week High | $43.18 | $25.17 |
| Indicator | ATRC | TSLX |
|---|---|---|
| Relative Strength Index (RSI) | 48.50 | 33.81 |
| Support Level | $36.11 | $19.63 |
| Resistance Level | $38.32 | $22.48 |
| Average True Range (ATR) | 1.46 | 0.55 |
| MACD | -0.07 | -0.22 |
| Stochastic Oscillator | 36.46 | 21.21 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.